Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Multiple Psychedelics Companies Come Together In a Watershed Moment For Psilocybin Therapy

Apr 4 • 3 min read

On January 5, 2022, Health Canada amended their Food and Drug Regulations to allow practitioners to request access to previously prohibited drugs such as psilocybin, MDMA, and other psychedelic treatments through a new Special Access Program (SAP). The amendment which reversed a policy from 2013 that prohibited special access to restricted drugs was seen as…

PRO: Rapid Reactions To ATAI’s 2021 Year-End Financial Results

Apr 1 • 1 min read

atai Life Sciences (ATAI), the largest pureplay clinical-stage psychedelic company in our index, just reported financial results for the fourth quarter and full-year ended December 31, 2021. The announcement falls on the heels of Compass Pathways (CMPS), Field Trip Health (FTRP), and Mind Medicine (MNMD) all announcing their year-end results, marking a suitable time for…

PRO: Rapid Reactions To Mind Medicine’s 2021 Year-End Financial Results

Mar 29 • 1 min read

Mind Medicine (MindMed) Inc. (MNMD), one of the sector’s largest clinical stage biopharmaceutical companies focused on developing novel products to treat brain health disorders, reported its financial results for the full-year ended December 31, 2021 earlier this week. Like most companies in the space, it’s been relatively difficult to report meaningful revenue. And MindMed, despite…

PRO: Companies Focused on DMT

Mar 18 • 3 min read

Nothing included herein shall be deemed to be or construed to be investment, financial, business, legal and/or tax advice. All written materials herein are being presented solely as the opinion of the author. If you have any questions, please contact Psychedelic Invest at questions@psychedelicinvest.com. Today, I’m gonna be talking about two companies – Biomind labs…

PRO: A Deeper Dive Into Seelos Therapeutics

Mar 11 • 1 min read

Earlier this week, we reported on Seelos Therapeutic‘s recent news and clinical updates. You can read that here. But we wouldn’t be doing our job if we didn’t dive in deeper. So here is Adam’s video taking a closer look at Seelos Therapeutics, the market’s sentiment with their recent updates, and comparisons with other companies…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253